标准化定量与视觉评估预测新诊断弥漫大B细胞淋巴瘤肿瘤体积与结局的比较研究
本研究对118例新诊断DLBCL患者的治疗前18F-FDG PET/CT进行定量与视觉分析,定量采用Hermes TumourFinder获取MTV2.5和MTV41。结果显示三位核医学医师的视觉二分预测均能分层PFS,而定量MTV2.5和MTV41及TLG均未与PFS显著相关。
要点
- 视觉二分预测可将患者分为预后好/差组,三位阅片者log-rank P分别为0.002、0.016、0.012。
- 定量MTV2.5的log-rank P=0.11,MTV41的P=0.76,TLG2.5的P=0.14,TLG41的P=0.34,均未达显著。
- 视觉评估的观察者间一致性为Fleiss kappa 0.47,属中等一致。
核心结论
- 经验丰富的阅片者对淋巴瘤18F-FDG PET/CT的无监督主观视觉判断对一线治疗后结局的预测出乎意料地好。
- 研究提示非标准化临床判断的重要性,并显示仅依赖半自动MTV测量可能丢失有价值的预后信息。
研究设计与样本
- 对118例新诊断DLBCL患者的治疗前18F-FDG PET/CT扫描进行定量与视觉分析。
- 定量分析使用Hermes TumourFinder获取MTV2.5(SUV 2.5截断)和MTV41(41% SUVmax等轮廓截断)。
- 视觉评估包括二分预测(预后好/差)、基于视觉模拟量表的肿瘤负荷(MTVVAS)和估计体积(eMTV),由三位对临床结局设盲的经验丰富核医学医师完成。
- 采用Kaplan-Meier曲线和log-rank检验评估无进展生存,采用Fleiss kappa评估多名观察者间变异。
主要发现
- 定量分析中,ROC确定的MTV2.5截断对PFS预测的log-rank P=0.11,似乎优于MTV41(log-rank P=0.76)。
- TLG2.5(log-rank P=0.14)和TLG41(log-rank P=0.34)与结局无关。
- 视觉分析中,三位阅片者均能将患者分为预后好/差组(阅片者A log-rank P=0.002,阅片者B P=0.016,阅片者C P=0.012),观察者间一致性为Fleiss kappa 0.47。
- MTVVAS和eMTV与结局无一致相关性。
关键数值与推荐
- 定量指标:MTV2.5(SUV 2.5截断)、MTV41(41% SUVmax等轮廓截断)、TLG2.5、TLG41。
- 视觉指标:二分预测(预后好/差)、MTVVAS、eMTV。
- 生存分析:Kaplan-Meier曲线和log-rank检验;观察者间一致性:Fleiss kappa。
- MTV2.5截断由ROC确定。
临床怎么用
- 在DLBCL的18F-FDG PET/CT预后评估中,经验丰富阅片者的视觉二分判断可有效分层患者PFS。
- 不应仅依赖半自动MTV测量,视觉评估可能提供额外的预后信息。
局限性
- 视觉评估的观察者间一致性仅为中等(Fleiss kappa 0.47)。
- MTVVAS和eMTV与结局无一致相关性。
- 样本量有限(118例),需进一步验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Semi-automated quantitative measurement of metabolic tumor volume (MTV) for prognosis in diffuse large B-Cell lymphoma (DLBCL) has gained considerable interest lately. However, simple tumor volume measures may be inadequate for assessment of prognosis in DLBCL as other characteristics such as growth pattern and metabolic heterogeneity may be just as important. In addition, MTV measurements require delineation of tumor lesions by semi-automated software, which can be time-consuming. We hypothesized that a simple visual assessment of tumor volume performs as well as standardized MTV measurements in DLBCL prognostication. MATERIALS AND METHODS: Quantitative and visual analyses of pre-therapy 18F-FDG PET/CT scans in 118 patients with newly diagnosed DLBCL were conducted. Quantitative analyses were performed using Hermes TumourFinder® to obtain MTV2.5 (SUV 2.5 cut-off) and MTV41 (41% SUVmax isocontour cut-off). Visual assessments included a binary prediction (good/poor prognosis) as well as tumor burden based on a visual analog scale (MTVVAS) and an estimated volume (eMTV). Three experienced nuclear medicine physicians who were blinded to clinical outcome performed visual evaluations. Progression-free survival was evaluated by Kaplan-Meier curves and log-rank test. Inter-observer variability was evaluated by Fleiss' kappa for multiple observers. RESULTS: In the quantitative analysis, a ROC-determined MTV2.5 cut-off (log-rank p = 0.11) seemed to outperform MTV41 (log-rank p = 0.76) for PFS prediction. TLG2.5 (log-rank p = 0.14) and TLG41 (log-rank p = 0.34) were not associated with outcomes. By visual analysis, all three reviewers were able to stratify patients into good/poor prognosis (reviewer A log-rank p = 0.002, reviewer B log-rank p = 0.016, and reviewer C log-rank p = 0.012) with fair inter-observer agreement (Fleiss' kappa 0.47). MTVVAS and eMTV were not consistently correlated with the outcome. CONCLUSION: Predictions of outcome after first-line treatment for DLBCL were surprisingly good when left to the unsupervised, subjective judgment of experienced readers of lymphoma 18F-FDG-PET/CT. The study highlights the importance of non-standardized clinical judgments and shows potential loss of valuable prognostic information when relying solely on semi-automated MTV measurements.
引用
- Gormsen LC, Vendelbo MH, Pedersen MA, et al. A comparative study of standardized quantitative and visual assessment for predicting tumor volume and outcome in newly diagnosed diffuse large B-cell lymphoma staged with 18F-FDG PET/CT. EJNMMI Res. 2019. PMID: 31054023. doi:10.1186/s13550-019-0503-z
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。